【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Pathophysiology
06.3 Epidemiology
06.4 Diagnosis
06.5 Staging
06.5.1 Staging: Colon Cancer
06.5.2 Staging: Rectal Cancer
06.6 Management
06.7 Economic Burden
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.2.1 Colorectal Cancer Drugs Market in US
07.2.2 Colorectal Cancer Drugs Market in Germany
07.2.3 Colorectal Cancer Drugs Market in Spain
07.2.4 Colorectal Cancer Drugs Market in Japan
07.2.5 Colorectal Cancer Drugs Market in China
07.3 Five Forces Analysis
08.Market Segmentation by Type of Molecules
08.1 Small molecules
08.2 Biologics
09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10.Geographical Segmentation
10.1 Colorectal Cancer Drugs Market in Americas
10.1.1 Market Size and Forecast
10.2 Colorectal Cancer Drugs Market in EMEA
10.2.1 Market Size and Forecast
10.3 Colorectal Cancer Drugs Market in APAC
10.3.1 Market Size and Forecast
11.Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany
11.4 Spain
11.5 China
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Competitive Assessment of Top Drugs for Colorectal Cancer
19.2.2 F. Hoffmann-La Roche
19.2.3 Merck Serono
19.2.4 Bristol-Myers Squibb
19.2.5 Amgen
19.2.6 Sanofi
19.2.7 Bayer
19.3 Other and Future Prominent Vendors
20.Key Takeaways
21.Key Vendor Analysis
21.1 Amgen
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Product Portfolio by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Bayer
21.2.1 Key facts
21.2.2 Business overview
21.2.3 Business segmentation by revenue 2014
21.2.4 Business segmentation by revenue 2013 and 2014
21.2.5 Geographical segmentation by revenue 2014
21.2.6 Business strategy
21.2.7 Recent developments
21.2.8 SWOT analysis
21.3 Bristol-Myers Squibb Co.
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Key Product Offerings
21.3.4 Revenue by Geography
21.3.5 Business Strategy
21.3.6 Key Information
21.3.7 SWOT Analysis
21.4 F. Hoffmann-La Roche Ltd.
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Sales by Geography
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 Merck Serono
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Geographical Segmentation by Revenue 2013
21.5.4 Business Strategy
21.5.5 Recent Developments
21.5.6 SWOT Analysis
21.6 Sanofi SA
21.6.1 Key Facts
21.6.2 Business Description
21.6.3 Business Segmentation
21.6.4 Revenue by Business Segmentation
21.6.5 Revenue Comparison 2012 and 2013
21.6.6 Sales by Geography
21.6.7 Business Strategy
21.6.8 Key Developments
21.6.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Drivers and Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 3: Diagnosis of Colorectal Cancer
Exhibit 4: Management of Colorectal Cancer
Exhibit 5: A Snapshot of the Economic Burden of the Global Colorectal Cancer Drugs Market
Exhibit 6: Snapshot of the Global Colorectal Cancer Drugs Market
Exhibit 7: Global Colorectal Cancer Drugs Market 2014-2019 ($ millions)
Exhibit 8: Colorectal Cancer Drugs Market in US 2014-2019 ($ millions)
Exhibit 9: Colorectal Cancer Drugs Market in Germany 2014-2019 ($ millions)
Exhibit 10: Colorectal Cancer Drugs Market in Spain 2014-2019 ($ millions)
Exhibit 11: Colorectal Cancer Drugs Market in Japan 2014-2019 ($ millions)
Exhibit 12: Colorectal Cancer Drugs Market in China 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules
Exhibit 14: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules, 2014
Exhibit 15: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration
Exhibit 16: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration, 2014
Exhibit 17: Global Colorectal Cancer Drugs Market by Geographical Segmentation 2014
Exhibit 18: Colorectal Cancer Drugs Market in Americas 2014-2019 ($ millions)
Exhibit 19: Colorectal Cancer Drugs Market in EMEA 2014-2019 ($ millions)
Exhibit 20: Colorectal Cancer Drugs Market in APAC 2014-2019 ($ millions)
Exhibit 21:
Exhibit 22: Drivers of the Global Colorectal Cancer Drugs Market
Exhibit 23: Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 24: Trends of the Global Colorectal Cancer Drugs Market
Exhibit 25: YoY Growth Rate of the Major Colorectal Cancer Drugs 2010-2014 ($ millions)
Exhibit 26: F. Hoffmann-La Roche: Product Portfolio
Exhibit 27: Avastin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 28: Avastin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 29: YoY Revenues and Growth Rate of Avastin in the US 2010-2014 ($ millions)
Exhibit 30: YoY Revenues and Growth Rate of Avastin in Europe 2010-2014 ($ millions)
Exhibit 31: YoY Revenues and Growth Rate of Avastin in Japan 2010-2014 ($ millions)
Exhibit 32: YoY International Revenues and Growth Rate of Avastin 2010-2014 (Except US, Europe, Japan) ($ millions)
Exhibit 33: Xeloda: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 34: Xeloda: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 35: YoY Revenues and Growth Rate of Xeloda in the US ($ millions)
Exhibit 36: YoY Revenues and Growth Rate of Xeloda in Europe 2010-2014 ($ millions)
Exhibit 37: YoY Revenues and Growth Rate of Xeloda in Japan 2010-2014 ($ millions)
Exhibit 38: YoY International Revenues and Growth Rate of Xeloda (Except US, Europe, Japan) ($ millions)
Exhibit 39: Merck Serono: Product Portfolio
Exhibit 40: Erbitux: Revenue and YoY Growth Rate except US and Canada 2010-2014 ($ millions)
Exhibit 41: Erbitux: Region-wise Revenues 2012-2014 ($ millions)
Exhibit 42: Erbitux: Revenue and YoY Growth Rate in Europe 2012-2014 ($ millions)
Exhibit 43: Erbitux: Revenue and YoY Growth Rate in Emerging Markets 2012-2014 ($ millions)
Exhibit 44: Erbitux: Revenue and YoY Growth Rate in ROW 2012-2014 ($ millions)
Exhibit 45: Bristol-Myers Squibb: Product Portfolio
Exhibit 46: Erbitux: Revenue and YoY Growth Rate in US and Canada 2010-2014 ($ millions)
Exhibit 47: Amgen: Product Portfolio
Exhibit 50: Vectibix: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 51: Vectibix: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 52: Sanofi: Product Portfolio
Exhibit 53: Eloxatin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 54: Eloxatin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 55: YoY Revenues and Growth Rate of Eloxatin in the US ($ millions)
Exhibit 56: YoY Revenues and Growth Rate of Eloxatin in Europe ($ millions)
Exhibit 57: YoY Revenues and Growth Rate of Eloxatin in Emerging Markets ($ millions)
Exhibit 58: YoY Revenues and Growth Rate of Eloxatin in ROW 2010-2014 ($ millions)
Exhibit 59: Zaltrap: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 60: Zaltrap: Region-wise Revenue 2013-2014 ($ millions)
Exhibit 61: Bayer: Product Portfolio
Exhibit 62: Stivarga: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 63: Key Takeaways: Global Colorectal Cancer Drugs Market 2015-2019
Exhibit 64: Amgen: Business Segmentation by Revenue 2013
Exhibit 65: Amgen: Product Portfolio by Revenue 2013
Exhibit 66: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 67: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 68: Bayer: Business segmentation by revenue 2014
Exhibit 69: Bayer: Business segmentation by revenue 2013 and 2014 (US$ billion)
Exhibit 70: Bayer: Geographical segmentation by revenue 2014
Exhibit 71: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 72: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 73: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 74: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 75: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 76: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 77: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 78: Sanofi SA: Business Segmentation
Exhibit 79: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 80: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 81: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル:大腸癌治療薬の世界市場2015-2019■ 英文:Global Colorectal Cancer Drugs Market 2015-2019
■ 発行日:2015年6月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6118
■ 調査対象地域:グローバル
- 医療廃棄物管理の世界市場2015-2022According to Stratistics MRC, the Global Medical Waste Management Market is valued at $10.78 billion in 2015 and is expected to grow at a CAGR of 5.9% to reach $16.2 billion by 2022. Huge quantity of waste generated by healthcare is one of the key factors driving the market growth. Rapidly growing healthcare industry will provide lucrative market opportunities for the service providers in the mark …
- スマートグリッド市場レビュー:August 2013Smart Grid Review - August 2013 Summary GlobalData announces the release of its monthly smart grid newsletter for August 2013. The newsletter provides update on the global developments related to smart grid deployment across the globe during the month of July 2013. Scope - Market prospect for companies providing smart grid systems - Key product launch in power grids - Major news and deals in smart …
- 世界のタレントマネジメントソフトウェア(Talent Management Software)市場動向(2014~2018)TechNavio's analysts forecast the Global Talent Management Software market to grow at a CAGR of 17.59 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to streamline HR functions. The Global Talent Management Software market has also been witnessing the increasing popularity of cloud computing technology. However, the difficulty in selecting t …
- 世界の固定衛星業務(FSS)市場:テレビ・チャンネル放送、コンテンツ/ビデオ配信、バックホール、ブロードバンドサービス等About Fixed Satellite Service A fixed satellite service (FSS) is a satellite service that uses geosynchronous satellites for broadcasting purposes such as TV and radio, telecommunications, and satellite communication used by government and military organizations. An FSS offers services under two major category: wholesale services and managed services. The satellites used for FSS generally have a l …
- 世界主要国における肺炎検査市場2015The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 世界のサプライチェーン分析:ノートパソコン市場The prevalence of smart handheld devices continues to put a dent in the notebook PC market in 2015. Global notebook PC market has been challenged since 2012, after leading the personal PC market for many years. In 2014, Microsoft's termination of its Windows XP support coupled with the rollout of low-cost Windows notebook PCs had succeeded in slowing the decline. Additionally, the decision of Sony …
- 床材の世界市場:材料別(カーペット・ラグ、弾性床材)、非弾性床材別(セラミック、石材、木材、ラミネート)、最終用途別(住宅、非住宅)、地域別予測Global Flooring Market to reach USD 506.6 billion by 2025. Global Flooring Market valued approximately USD 307.6 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2017-2025. Key factors which give growth to the Flooring market are Increase in renovation & remodeling activities, rapid urbanization, and increase in investments in the constru …
- 世界のブタジエン市場2015The Global Butadiene Industry Report 2015 is a professional and in-depth study on the current state of the Butadiene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Butadiene market analysis is provided for the international markets including development trends, competitive landscape analysis, and …
- 世界主要国のシクロスポラ検査(医療機器)市場The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- Elvitegravir (HIV):市場予測と分析(~2022)Elvitegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Elvitegravir (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS …
- スコッチ・ウイスキーの世界市場2015-2019Technavio's market research analyst predicts the global scotch whiskey market to witness a steady growth at a CAGR of around 5% during the forecast period. The rise in disposable income and the growing demand for premium whiskey has been fueling the growth of this market. Around 88% of consumers globally, consider whisky as an affordable luxury, which is driving manufacturers to launch more premiu …
- パンティーライナーの世界市場2017-2021About PantylinerPantyliners are used by women during premenstrual and postmenstrual cycle or vaginal discharge. Made of absorbent materials, they are used for feminine hygiene during light vaginal discharge. Technavio’s analysts forecast the global pantyliner market to grow at a CAGR of 5.01% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growt …
- Imprime PGG:大腸癌治療薬市場分析Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge bur …
- Southwestern Energy Company社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 世界の難燃剤市場:アルミニウム三水和物、酸化アンチモニー、臭素系、塩素系、有機リン系Flame retardant chemicals find major use in different end-user industries. This enables their use in variety of consumer and industrial applications. The major end-user industry of flame retardant chemicals is building & construction, which accounts for a majority of their usage, followed by wires & cables, electronics, automotive & construction, textiles, and other applications. Of the five main …